Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Di Minno MN
  • Cavalca V
  • D'angelo A
  • Squellerio I
  • Coppola A
  • Tremoli E
  • Di Minno G
  • MESH
  • Adult
  • Biological Markers
  • Female
  • Humans
  • Incidence
  • Isoprostanes
  • Italy
  • Male
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Survival Rate
  • Thrombosis

Unbound MEDLINE

Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up.

Links

  • Publisher Full Text
  • Authors

    Di Minno MN, Cavalca V, D'angelo A, Squellerio I, Coppola A, Tremoli E, Di Minno G

    Source

    Thrombosis research 129:2 2012 Feb pg 208-11

    MeSH

    Adult
    Biological Markers
    Female
    Humans
    Incidence
    Isoprostanes
    Italy
    Male
    Prognosis
    Risk Assessment
    Risk Factors
    Survival Analysis
    Survival Rate
    Thrombosis

    Pub Type(s)

    Letter
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22035633

    Related Citations

    • Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    • Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries.
    • Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).
    • Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients.
    • [Increased rate of stent thrombosis with DES].
    • Clustering of ventricular arrhythmias: a therapeutic opportunity or strictly a marker of poor prognosis?
    • Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery.
    • Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved